{"slideshow_credits": null, "snippet": "The company said the drug reduced levels of plaque in the brain and significantly improved cognition in a small early-stage study.", "abstract": "Biotechnology company Biogen Idec is planning a late-stage trial of its experimental treatment for Alzheimer's disease after drug significantly improved cognition in a small early-stage study.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [], "organization": "REUTERS", "original": "By REUTERS", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/12/03/business/biogen-idec-alzheimers-drug-to-receive-late-stage-study.html", "lead_paragraph": "The company said the drug reduced levels of plaque in the brain and significantly improved cognition in a small early-stage study.", "headline": {"main": "Biogen Idec Alzheimer\u2019s Drug to Receive Late-Stage Study", "print_headline": "Biogen Idec Alzheimer\u2019s Drug to Receive Late-Stage Study", "content_kicker": "Business Briefing"}, "_id": "547e661438f0d84a61c0e8c5", "word_count": "124", "multimedia": [], "pub_date": "2014-12-03T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Alzheimer's Disease", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Biogen Idec Inc", "name": "organizations", "is_major": "Y", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Biotechnology and Bioengineering", "name": "subject", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "Brief"}